112 related articles for article (PubMed ID: 17471843)
1. [Antiendothelial cell antibodies as a risk factor of atherosclerosis in systemic lupus erythematosus].
Fischer K; Brzosko M; Walecka A; Ostanek L; Sawicki M
Ann Acad Med Stetin; 2006; 52 Suppl 2():95-9. PubMed ID: 17471843
[TBL] [Abstract][Full Text] [Related]
2. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].
Fischer K
Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227
[TBL] [Abstract][Full Text] [Related]
3. [Significance of antiphospholipid syndrome and antiphospholipid antibodies in patients with systemic lupus erythematosus in estimation of risk of subclinical atherosclerosis development].
Fischer K; Brzosko M; Walecka A; Ostanek L; Sawicki M
Pol Arch Med Wewn; 2007; 117 Suppl():13-7. PubMed ID: 18778013
[TBL] [Abstract][Full Text] [Related]
4. Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus.
Falaschi F; Ravelli A; Martignoni A; Migliavacca D; Sartori M; Pistorio A; Perani G; Martini A
Arthritis Rheum; 2000 Jun; 43(6):1405-9. PubMed ID: 10857801
[TBL] [Abstract][Full Text] [Related]
5. Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus.
Yoshio T; Masuyama J; Sumiya M; Minota S; Kano S
J Rheumatol; 1994 Nov; 21(11):2058-63. PubMed ID: 7869310
[TBL] [Abstract][Full Text] [Related]
6. Decreased binding of annexin v to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus.
Cederholm A; Svenungsson E; Jensen-Urstad K; Trollmo C; Ulfgren AK; Swedenborg J; Fei GZ; Frostegård J
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):198-203. PubMed ID: 15539620
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus.
Doria A; Shoenfeld Y; Wu R; Gambari PF; Puato M; Ghirardello A; Gilburd B; Corbanese S; Patnaik M; Zampieri S; Peter JB; Favaretto E; Iaccarino L; Sherer Y; Todesco S; Pauletto P
Ann Rheum Dis; 2003 Nov; 62(11):1071-7. PubMed ID: 14583570
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
9. Carotid subclinical atherosclerosis is associated with disease activity but not vitamin D in Korean systemic lupus erythematosus.
Jung JY; Koh BR; Bae CB; Kim HA; Suh CH
Lupus; 2014 Dec; 23(14):1517-22. PubMed ID: 25059488
[TBL] [Abstract][Full Text] [Related]
10. Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study).
Colombo BM; Cacciapaglia F; Puntoni M; Murdaca G; Rossi E; Rodriguez G; Nobili F; Pisciotta L; Bertolini S; Moccetti T; Dentali F; Steidl L; Ciprandi G; Afeltra A; Indiveri F; Puppo F
Autoimmun Rev; 2009 Feb; 8(4):309-15. PubMed ID: 18976721
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor-acetylhydrolase and other novel risk and protective factors for cardiovascular disease in systemic lupus erythematosus.
Cederholm A; Svenungsson E; Stengel D; Fei GZ; Pockley AG; Ninio E; Frostegård J
Arthritis Rheum; 2004 Sep; 50(9):2869-76. PubMed ID: 15457454
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosus.
de Leeuw K; Smit AJ; de Groot E; van Roon AM; Kallenberg CG; Bijl M
Atherosclerosis; 2009 Oct; 206(2):546-50. PubMed ID: 19389674
[TBL] [Abstract][Full Text] [Related]
13. Reduced carotid intima-media thickness in systemic lupus erythematosus patients treated with cyclosporine A.
Oryoji K; Kiyohara C; Horiuchi T; Tsukamoto H; Niiro H; Shimoda T; Akashi K; Yanase T
Mod Rheumatol; 2014 Jan; 24(1):86-92. PubMed ID: 24261763
[TBL] [Abstract][Full Text] [Related]
14. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
[TBL] [Abstract][Full Text] [Related]
15. Integrated backscatter analysis of carotid intima-media complex in patients with systemic lupus erythematosus.
Rossi M; Mosca M; Tani C; Franzoni F; Santoro G; Bombardieri S
Clin Rheumatol; 2008 Dec; 27(12):1485-8. PubMed ID: 18654734
[TBL] [Abstract][Full Text] [Related]
16. Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus.
López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; López-Mejías R; Benavente L; Mozo L; Caminal-Montero L; González-Gay MA; Suárez A
Thromb Haemost; 2017 Nov; 117(11):2194-2206. PubMed ID: 29044294
[TBL] [Abstract][Full Text] [Related]
17. Natural immune response involving anti-endothelial cell antibodies in normal and lupus pregnancy.
Mendonca LL; Khamashta MA; Cuadrado MJ; Bertolaccini ML; Hughes GR
Arthritis Rheum; 2000 Jul; 43(7):1511-5. PubMed ID: 10902753
[TBL] [Abstract][Full Text] [Related]
18. Anti-endothelial cell antibodies in patients with systemic lupus erythematosus.
Liu MF; Lei HY
J Formos Med Assoc; 1991 Mar; 90(3):221-4. PubMed ID: 1677395
[TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women.
El-Magadmi M; Bodill H; Ahmad Y; Durrington PN; Mackness M; Walker M; Bernstein RM; Bruce IN
Circulation; 2004 Jul; 110(4):399-404. PubMed ID: 15262847
[TBL] [Abstract][Full Text] [Related]
20. IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner.
Carvalho D; Savage CO; Isenberg D; Pearson JD
Arthritis Rheum; 1999 Apr; 42(4):631-40. PubMed ID: 10211876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
